Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Sierra Oncology, Inc. (SRRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/01/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 161,712 shares
@ $55, valued at
$8.9M
Disposed/sold 2,735,853 shares
@ $55, valued at
$150.5M
Disposed/sold 431,947 shares
@ $55, valued at
$23.8M
Disposed/sold 324,740 options to buy
@ $13.2, valued at
$4.3M
Disposed/sold 1,455,384 options to buy
@ $13.2, valued at
$19.2M
Disposed/sold 75,749 options to buy
@ $13.2, valued at
$999.9k
|
|
| 07/01/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 1,511,362 shares
@ $55, valued at
$83.1M
Disposed/sold 226,704 shares
@ $55, valued at
$12.5M
Disposed/sold 1,136,250 options to buy
@ $13.2, valued at
$15M
Disposed/sold 170,437 options to buy
@ $13.2, valued at
$2.2M
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Aggarwal Gaurav (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 2,735,853 shares
@ $55, valued at
$150.5M
Disposed/sold 1,500 options to buy
@ $13.87, valued at
$20.8k
Disposed/sold 6,874 options to buy
@ $13.98, valued at
$96.1k
Disposed/sold 6,000 options to buy
@ $18.11, valued at
$108.7k
Disposed/sold 1,455,384 options to buy
@ $13.2, valued at
$19.2M
|
|
| 07/01/2022 |
4
| Sinclair Andrew (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 1,314,127 shares
@ $55, valued at
$72.3M
Disposed/sold 1,500 options to buy
@ $13.868, valued at
$20.8k
Disposed/sold 6,874 options to buy
@ $13.98, valued at
$96.1k
Disposed/sold 6,000 options to buy
@ $18.11, valued at
$108.7k
Disposed/sold 871,125 options to buy
@ $13.2, valued at
$11.5M
|
|
| 07/01/2022 |
4
| Klencke Barbara (Chief Medical Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 10,000 shares
@ $55, valued at
$550k
Disposed/sold 5,000 shares
@ $55, valued at
$275k
Disposed/sold 11,744 options to buy
@ $268.2, valued at
$3.1M
Disposed/sold 2,061 options to buy
@ $263.2, valued at
$542.5k
Disposed/sold 11,399 options to buy
@ $72.8, valued at
$829.8k
Disposed/sold 1,749 options to buy
@ $58, valued at
$101.4k
Disposed/sold 4,508 options to buy
@ $94.4, valued at
$425.6k
Disposed/sold 4,999 options to buy
@ $78.4, valued at
$391.9k
Disposed/sold 167,091 options to buy
@ $13.31, valued at
$2.2M
Disposed/sold 49,000 options to buy
@ $12.15, valued at
$595.4k
Disposed/sold 30,000 options to buy
@ $16.73, valued at
$501.9k
|
|
| 07/01/2022 |
4
| Jagpal Sukhi (CFO) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 3,859 options to buy
@ $122.2, valued at
$471.6k
Disposed/sold 1,218 options to buy
@ $263.2, valued at
$320.6k
Disposed/sold 4,200 options to buy
@ $72.8, valued at
$305.8k
Disposed/sold 1,750 options to buy
@ $58, valued at
$101.5k
Disposed/sold 4,509 options to buy
@ $94.4, valued at
$425.6k
Disposed/sold 5,000 options to buy
@ $78.4, valued at
$392k
Disposed/sold 94,113 options to buy
@ $13.31, valued at
$1.3M
Disposed/sold 49,000 options to buy
@ $12.15, valued at
$595.4k
Disposed/sold 5,887 options to buy
@ $12.15, valued at
$71.5k
Disposed/sold 30,000 options to buy
@ $16.73, valued at
$501.9k
Disposed/sold 50,000 options to buy
@ $31.54, valued at
$1.6M
|
|
| 07/01/2022 |
4
| Pelzer Robert (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 671 options to buy
@ $268.2, valued at
$180k
Disposed/sold 970 options to buy
@ $82.4, valued at
$79.9k
Disposed/sold 625 options to buy
@ $45.2, valued at
$28.3k
Disposed/sold 625 options to buy
@ $130.8, valued at
$81.8k
Disposed/sold 750 options to buy
@ $26.4, valued at
$19.8k
Disposed/sold 16,686 options to buy
@ $13.98, valued at
$233.3k
Disposed/sold 6,000 options to buy
@ $18.11, valued at
$108.7k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Allen Andrew R (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 1,650 shares
@ $55, valued at
$90.8k
Disposed/sold 750 options to buy
@ $26.4, valued at
$19.8k
Disposed/sold 1,250 options to buy
@ $76.8, valued at
$96k
Disposed/sold 625 options to buy
@ $130.8, valued at
$81.8k
Disposed/sold 12,030 options to buy
@ $13.98, valued at
$168.2k
Disposed/sold 6,000 options to buy
@ $18.11, valued at
$108.7k
|
|
| 07/01/2022 |
4
| Collard Craig A (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 13,500 shares
@ $55, valued at
$742.5k
Disposed/sold 10,000 options to buy
@ $13.88, valued at
$138.8k
Disposed/sold 6,000 options to buy
@ $18.11, valued at
$108.7k
|
|
| 07/01/2022 |
4
| DILLY STEPHEN GEORGE (CEO and President) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 5,000 shares
@ $55, valued at
$275k
Disposed/sold 520,000 options to buy
@ $14.03, valued at
$7.3M
Disposed/sold 260,000 options to buy
@ $12.15, valued at
$3.2M
Disposed/sold 92,000 options to buy
@ $16.73, valued at
$1.5M
Disposed/sold 165,000 options to buy
@ $31.54, valued at
$5.2M
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Turner William D. (Chief Reg & Tech Ops Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 75,000 options to buy
@ $12.05, valued at
$903.8k
Disposed/sold 49,000 options to buy
@ $12.15, valued at
$595.4k
Disposed/sold 12,300 options to buy
@ $16.73, valued at
$205.8k
Disposed/sold 35,000 options to buy
@ $31.54, valued at
$1.1M
|
|
| 07/01/2022 |
4
| Norrett Kevin (Chief Business Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 100,000 options to buy
@ $12.05, valued at
$1.2M
Disposed/sold 49,000 options to buy
@ $12.15, valued at
$595.4k
Disposed/sold 11,700 options to buy
@ $16.73, valued at
$195.7k
Disposed/sold 35,000 options to buy
@ $31.54, valued at
$1.1M
|
|
| 07/01/2022 |
4
| Oliger Christy J. (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 18,000 options to buy
@ $17.7575, valued at
$319.6k
|
|
| 07/01/2022 |
4
| Erbez Georgia (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 18,000 options to buy
@ $17.7575, valued at
$319.6k
|
|
| 06/17/2022 |
4
| Turner William D. (Chief Reg & Tech Ops Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 12,250 options to buy
@ $12.15, valued at
$148.8k
|
|
| 06/17/2022 |
4
| Norrett Kevin (Chief Business Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 12,250 options to buy
@ $12.15, valued at
$148.8k
|
|
| 06/17/2022 |
4
| Klencke Barbara (Chief Medical Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 12,250 options to buy
@ $12.15, valued at
$148.8k
|
|
| 06/17/2022 |
4
| Jagpal Sukhi (CFO) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 12,250 options to buy
@ $12.15, valued at
$148.8k
|
|
| 06/17/2022 |
4
| DILLY STEPHEN GEORGE (CEO and President) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 65,000 options to buy
@ $12.15, valued at
$789.8k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed of 175,000 shares
@ $0
Disposed of 1,964,771 shares
@ $0
Acquired 5,023 shares
@ $0
Acquired 2,152 shares
@ $0
Acquired 7,175 shares
@ $0
Acquired 588 shares
@ $0
Acquired 252 shares
@ $0
Acquired 840 shares
@ $0 |
|
| 04/07/2022 |
4
| Turner William D. (Chief Reg & Tech Ops Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Sold 100 shares
@ $37.09, valued at
$3.7k
Sold 6,347 shares
@ $37.2474, valued at
$236.4k
Exercised 100 options to buy
@ $12.05, valued at
$1.2k
Exercised 6,347 options to buy
@ $12.05, valued at
$76.5k
|
|
| 04/04/2022 |
4
| Thomson Mary Christina (General Counsel, CCO & Sec'y) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Sold 2,000 shares
@ $35.1384, valued at
$70.3k
Exercised 2,000 options to buy
@ $13.04, valued at
$26.1k
|
|
| 03/22/2022 |
4
| Turner William D. (Chief Reg & Tech Ops Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Sold 100 shares
@ $37.05, valued at
$3.7k
Exercised 100 options to buy
@ $12.05, valued at
$1.2k
|
|
| 03/17/2022 |
4
| Turner William D. (Chief Reg & Tech Ops Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Sold 3,453 shares
@ $37.0558, valued at
$128k
Exercised 3,453 options to buy
@ $12.05, valued at
$41.6k
|
|
| 03/14/2022 |
4
| DILLY STEPHEN GEORGE (CEO and President) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 165,000 options to buy
@ $31.54, valued at
$5.2M
|
|
| 03/14/2022 |
4
| Jagpal Sukhi (CFO) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 50,000 options to buy
@ $31.54, valued at
$1.6M
|
|
| 03/14/2022 |
4
| Klencke Barbara (Chief Medical Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 50,000 options to buy
@ $31.54, valued at
$1.6M
|
|
| 03/14/2022 |
4
| Norrett Kevin (Chief Business Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 35,000 options to buy
@ $31.54, valued at
$1.1M
|
|
| 03/14/2022 |
4
| Turner William D. (Chief Reg & Tech Ops Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 35,000 options to buy
@ $31.54, valued at
$1.1M
|
|
| 03/14/2022 |
4
| Thomson Mary Christina (General Counsel, CCO & Sec'y) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 35,000 options to buy
@ $31.54, valued at
$1.1M
|
|
|
|
|